More importantly, inactivation of this signaling cascade paralleled with administration of anti-PD-L1 therapy could improve efficacy of checkpoint inhibitors in orthotopic HCC model and prevent immune evasion [188]. This evidence concerns the gene CD274 and hepatocellular carcinoma.